Cosmetic cross-reference Noindex: medium evidence

Tocopherols

CAS 1406-66-2

Tocopherols (CAS 1406-66-2) is a pharmaceutical compound with 0 bioactivity targets and 967 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
967
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EPA DSSTox

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Tocopherols
CAS Number
1406-66-2
Source Match
EPA DSSTox
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE DSSTox identifiers DTXSID8021357

Cross-Reference to Chemicals

Same-CAS substance identity is available in the industrial chemicals vertical.

Tocopherols is linked to DTXSID8021357 in DSSTox identifiers.

View industrial chemical data →
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Tocopherols used for in pharmaceutical contexts?

Tocopherols (CAS 1406-66-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Tocopherols?

Tocopherols has 967 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal distension, Abdominal pain, Abdominal pain upper, Activated partial thromboplastin time prolonged, Adrenal insufficiency. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Tocopherols also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Tocopherol (Vitamin E) with EU status "restricted".

What clinical phase is Tocopherols in?

No phase 1-4 clinical development badge is rendered for Tocopherols because the matched compound identifier rows do not contain a max-phase value.